Noninvasive Monitoring of Cerebrovascular Reactivity with Near Infrared Spectroscopy in Head-Injured Patients

作者：Zweifel Christian^*; Castellani Gianluca; Czosnyka Marek; Helmy Adel; Manktelow Anne; Carrera Emmanuel; Brady Kenneth M; Hutchinson Peter J A; Menon David K; Pickard John D; Smielewski Peter

来源：Journal of Neurotrauma, 2010, 27(11): 1951-1958.

DOI：10.1089/neu.2010.1388

• cerebrovascular pressure reactivity
• near infrared spectroscopy
• optimal arterial blood pressure
• optimal cerebral perfusion pressure
• cerebrovascular pressure reactivity
• total hemoglobin reactivity

Monitoring of cerebrovascular pressure reactivity (PRx) has diagnostic and prognostic value in head-injured patients, but requires invasive monitoring of intracranial pressure (ICP). Near infrared spectroscopy (NIRS) is a noninvasive method that is suitable for continuous detection of cerebral blood volume changes. We compared a NIRS-based index of cerebrovascular reactivity, called total hemoglobin reactivity (THx), against standard measurements of PRx in a prospective observational study. Forty patients with closed-head injury were monitored daily with arterial blood pressure (ABP), ICP, and a NIRS-based total hemoglobin index. PRx and THx were calculated as the moving correlation coefficients using 5-min time windows between 10-sec averaged values of ICP and ABP, and total hemoglobin index and ABP, respectively. A total of 120 recordings were performed between the median first (IQR 0.75-2) and fourth (IQR 2-6) day after head injury, giving a total duration of 1760 hours. PRx and THx demonstrated a significant association across averaged individual recordings (r=0.49, p<0.0001), and across patients (r=0.56, p=0.0002). Assessment of optimal cerebral perfusion pressure (CPP) and ABP using THx was possible in about 50% of recordings, and showed a significant agreement with the optimal CPP and ABP assessed with PRx. THx may be of diagnostic value to optimize therapy oriented toward restoration and continuity of cerebrovascular reactivity, especially in patients for whom direct ICP monitoring is not feasible.

• 出版日期2010-11